These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18126564)

  • 1. The production and some properties of Clostridium perfringens hyaluronidase.
    BYERS SO; TYTELL AA; LOGAN MA
    Arch Biochem; 1949 May; 22(1):66-86. PubMed ID: 18126564
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of hyaluronidase from Clostridium perfringens.
    BAKER EM; WEBSTER ME; FREEMAN ME; CARY SG; SANDERS AC
    Proc Soc Exp Biol Med; 1956 Jan; 91(1):24-7. PubMed ID: 13297698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effct of divalent cations on the production of hyaluronidase of Clostridium perfringens type A].
    Aleksandrowicz J; Mierzejewska H
    Med Dosw Mikrobiol; 1967; 19(4):347-51. PubMed ID: 4295546
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceleration of hyaluronidase production in the course of batch cultivation of Clostridium perfringens can be achieved with bacteriolytic enzymes.
    Zukaite V; Biziulevicius GA
    Lett Appl Microbiol; 2000 Mar; 30(3):203-6. PubMed ID: 10747251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of glucose and hyaluronic acid on hyaluronidase level in the supernatants of Clostridium perfringens type A].
    Meisel H; Aleksandrowicz J; Mierzejewska H
    Med Dosw Mikrobiol; 1966; 18(4):361-7. PubMed ID: 4289228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further purification of Cl. perfringens hyaluronidase].
    Klimacheva LV; Ispolatovskaia MV
    Vopr Med Khim; 1973; 19(6):641-4. PubMed ID: 4369570
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isolation and various properties of Cl. perfringens hyaluronidase].
    Klimacheva LV; Ispolatovskaia MV
    Vopr Med Khim; 1970; 16(4):381-6. PubMed ID: 4324119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological and some histochemical changes in the organism of guinea pigs caused by hyaluronidase from Cl. perfringens type A].
    Anosov IIa; Klimacheva LV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Sep; 48():133-6. PubMed ID: 4329698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of penicillin on the production of haemotoxin by Clostridium perfringens type A].
    MEISEL H; RYBICKA I; MEISEL P
    Pol Tyg Lek (Wars); 1949 Mar; 4(12):361-4. PubMed ID: 18150424
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of toxic enzymes of Clostridium perfringens BP6K on technologically important media including a medium with Tween 80.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):243-8. PubMed ID: 217931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of Clostridium perfringens.
    TYTELL AA
    Arch Biochem; 1949 Jul; 22(3):489. PubMed ID: 18134562
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of temperature on the development and toxin production of Clostridium perfringens. Optimum temperature ranges for clostridia].
    SASARMAN A; HORODNICEANU T
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():691-7. PubMed ID: 14497355
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of mastitis due to Clostridium perfringens.
    FOSS JO; NELSON CI
    North Am Vet; 1945 Oct; 26():604. PubMed ID: 21005505
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods for the production of the alpha and theta toxins of Clostridium welchii.
    ADAMS MH; HENDEE ED
    J Immunol; 1945 Oct; 51():249-56. PubMed ID: 21003540
    [No Abstract]   [Full Text] [Related]  

  • 15. The occurrence of vegetative cells of Clostridium perfringens in soil.
    SMITH LD; GARDNER MV
    J Bacteriol; 1949 Sep; 58(3):407. PubMed ID: 18139172
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of Clostridium perfringens in different aquatic environments in Greece.
    Bezirtzoglou E; Dimitriou D; Panagiou A; Kagalou I; Demoliates Y
    Microbiol Res; 1994 Jun; 149(2):129-34. PubMed ID: 7921894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of Clostridium perfringens selective chromogenic medium].
    Wang J; Chen P; Li Q; Ren C
    Wei Sheng Yan Jiu; 2013 Jul; 42(4):656-9. PubMed ID: 24024383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Beta2-Positive Clostridium perfringens Type A With Focal Duodenal Necrosis in Egg-Laying Chickens in the United States.
    França M; Barrios MA; Stabler L; Zavala G; Shivaprasad HL; Lee MD; Villegas AM; Uzal FA
    Avian Dis; 2016 Mar; 60(1):43-9. PubMed ID: 26953942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Clostridium perfringens toxin in patients suspected of having antibiotic-associated diarrhea.
    Kim YJ; Kim SH; Ahn J; Cho S; Kim D; Kim K; Lee H; Son H; Lee HJ; Yong D; Choi JY; Kim HR; Shin JH
    Anaerobe; 2017 Dec; 48():34-36. PubMed ID: 28655582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.